Earth's catastrophe, crazy black crystals begin to wreak havoc

Hibart's heart is filled with hope for his family and all those who are infected. They will no longer be helpless in the face of the virus, but will be able to find a path to recovery through the power of this technology.

The team worked hard to produce and distribute this new drug, and launched an extensive publicity and education campaign to get more people to understand and use it.

The patients gradually recovered and the infection rate was significantly reduced. However, Hibbart and his team found that some patients still complained of symptoms of dry, bitter mouth that were not fully relieved.

Professor Zhang organized a research team and decided to investigate the root cause of this problem in depth. They began to re-examine the experimental data and conduct further communication and observations with the patients.

During one patient interview, research team member Lisa carefully asked a woman being treated: “Can you tell me when your symptoms started?”

The woman replied in a low voice: "Probably not long after I started taking the medication, I started to feel dry in my mouth, and drinking water didn't help."

Lisa nodded slightly, and then continued to ask: "Do you feel your mouth is bitter?"

The lady covered her mouth with her hands and said slightly uncomfortable: "Yes, it's like having a bitter leaf in your mouth."

Hearing this description, Lisa suddenly thought of a possible reason. She told the woman: "Please be patient a little longer, I think we may have found the problem."

Subsequently, Lisa immediately told Professor Zhang and other members of the research team about the situation.

Professor Zhang frowned and they conducted further analysis in the laboratory. After some careful measurements and testing, they discovered that one of the drug's ingredients contained a chemical that produced a drying and bitter feeling in the mouth.

"That's the problem!" Professor Zhang said to himself.

To make sure their inferences were accurate, the team decided to conduct a series of experiments. They rationally adjusted the formula of the drug and tested it one by one in the laboratory.

After unremitting efforts, they finally succeeded in finding a new material that could replace the original drug ingredients. The new material not only effectively solves the problem of dry mouth and bitterness, but also improves the overall effect of the drug.

The team was filled with joy and pride, knowing they had taken an important step.

In the days that followed, they aggressively began producing and distributing the improved drug. At the same time, they conducted extensive publicity and education campaigns to educate people about this new drug formula and how to use it correctly.

Patients quickly experience significant improvements in symptoms and their mouths no longer feel dry and bitter. This brought them great relief and comfort, and also gave them greater confidence in medical technology.

However, Hibbart and team did not let down their guard. They understand that this is only part of the treatment process and that there are many questions and challenges that need to be addressed.

The team continues research in the hope of further improving the drug and finding more effective treatments. They cooperate with experts in various fields, share experience and knowledge, and strive to find new breakthrough points.

Soon after, they discovered a new clue that they believed would be the key to solving the problem of the spread of the virus.

The team organized an emergency meeting to discuss the new findings.

Queen Staffan leaned over and looked at the test report on the table. She said firmly: "This is an amazing discovery! If we can successfully use this clue, we will be able to completely control and eliminate this virus."

The team is full of anticipation and enthusiasm to explore this clue further. Everyone is investing in experiments and research, hoping to find new ways to deal with the virus as soon as possible.

Hibart and the team are extremely excited about this important breakthrough. They realized that by interfering with specific proteins of the virus, they could effectively inhibit the virus's ability to replicate and spread.

In order to verify the feasibility of this discovery, they quickly launched a series of rigorous experiments. Through the results of the experiment, they confirmed that this intervention indeed had a significant inhibitory effect on the virus.

Hibart immediately convened a meeting with the team to introduce this important breakthrough to everyone. He said: "We have discovered a new intervention that will be key to our further control of the spread of the virus. We need to study it in depth as soon as possible to identify more effective treatments."

Team members were extremely excited after hearing the news and expressed that they would go all out to carry out further research and experiments. Everyone knows that they are at the forefront of science and that their work will directly affect the fate of millions of patients.

In the following days, they invested a lot of time and energy in experiments and research. They continuously optimize intervention methods to find the optimal treatment plan.

At the same time, they have also conducted extensive cooperation with other medical research institutions and experts. By sharing experiences and knowledge, they can learn from and complement each other and continuously advance research progress.

After a period of hard work, they gradually discovered a more effective intervention method. This new treatment option can better inhibit the replication and spread of the virus while reducing patients' symptoms.

Hibbart and the team are extremely proud of this new breakthrough. They launched a series of clinical trials to verify the safety and effectiveness of the new solution.

During the clinical trial process, they actively cooperate with major hospitals and patient families. While they treat patients, they collect data and feedback to continuously improve and optimize treatment plans.

Over time, clinical trials gradually gathered significant results. The patient's recovery speed is significantly accelerated and the recurrence rate is significantly reduced. The good news spread throughout the medical community, and patients had high hopes for this new treatment option.

The team realizes that their work cannot stop, and they know that further improving the effectiveness and stability of the treatment plan is crucial to ultimately defeating this virus. However, they encountered a new problem - they needed a special material to add to the treatment plan.

Hibbart and his team members got together, and they began discussing how to find this special material. The laboratory became quiet and tense, and everyone was full of anticipation.

Lisa raised her head and looked at Professor Zhang, bit her lip, and said, "I once read about a material in the literature that is said to have strong antiviral capabilities. Maybe we can try it."

Professor Zhang thought for a moment and nodded. They decided to include the material in further research to see if it had the potential to become an important part of their treatment regimen.

The team began to actively collect relevant information about this material and contacted various research institutions and experts. They hope to soon have access to supplies of this material and opportunities for further research collaborations.

After some efforts, they finally contacted a scientist who specialized in materials research. The scientist showed great interest in their research project and expressed his willingness to cooperate with them.

In the following weeks, the team continued to discuss with the scientist to share research ideas and progress. They complement and learn from each other and work together to find the best research direction.